Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery Vehicles
Pharmaceutics · 28.02.2023 · 15 (3) · 798
DOI: 10.3390/pharmaceutics15030798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 28.02.2023. Verfasst von Zahra Khabir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Australian Research Council, Industrial Transformation Training Centre for Facilitated, Advancement of Australia's Bioactives (FAAB), Macquarie Unive…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, Australian Research Council Industrial Transformation Training Centre for Facilitated Advancement of Australia’s Bioactives, Office of the Chief Scientist and Engineer, Investment NSW.
Abstract (Originalsprache)
There is potential for cannabidiol to act as an analgesic, anxiolytic and antipsychotic active ingredient; however, there is a need to find alternate administration routes to overcome its low oral bioavailability. In this work, we propose a new delivery vehicle based on encapsulation of cannabidiol within organosilica particles as drug delivery vehicles, which are subsequently incorporated within polyvinyl alcohol films. We investigated the long-term stability of the encapsulated cannabidiol, as well as its release rate, in a range of simulated fluids with different characterization techniques, including Fourier Transform Infrared (FT-IR) and High-performance Liquid Chromatography (HPLC). Finally, we determined the transdermal penetration in an ex vivo skin model. Our results show that cannabidiol is stable for up to 14 weeks within polyvinyl alcohol films at a range of temperatures and humidity. Release profiles are first-order, consistent with a mechanism involving diffusion of the cannabidiol (CBD) out of the silica matrix. The silica particles do not penetrate beyond the stratum corneum in the skin. However, cannabidiol penetration is enhanced and is detected in the lower epidermis, which was 0.41% of the total CBD in a PVA formulation compared with 0.27% for pure CBD. This is partly due to an improvement of its solubility profile as it is released from the silica particles, but we cannot rule out effects of the polyvinyl alcohol. Our design opens a route for new membrane technologies for cannabidiol and other cannabinoid products, where administration via non-oral or pulmonary routes can lead to better outcomes for patient cohorts in a range of therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australian Research Council, Industrial Transformation Training Centre for Facilitated, Advancement of Australia's Bioactives (FAAB), Macquarie University, Sydney, NSW 2109, Australia.
- School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia.
- Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.
- EncapSolutions Pty. Ltd., 11 Julius Avenue, North Ryde, NSW 2113, Australia.
ORCID-Profile: Zahra Khabir, Alfonso Garcia-Bennett
Förderung
- Australian Research Council
- Australian Research Council Industrial Transformation Training Centre for Facilitated Advancement of Australia’s Bioactives
- Office of the Chief Scientist and Engineer, Investment NSW
Zitieren
APA
Khabir, Z., Partalis, C., Panchal, J. V., Deva, A., Khatri, A., & Garcia-Bennett, A. (2023). Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery Vehicles. Pharmaceutics, 15(3), 798. https://doi.org/10.3390/pharmaceutics15030798
Vancouver
Khabir Z, Partalis C, Panchal JV, Deva A, Khatri A, Garcia-Bennett A. Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery Vehicles. Pharmaceutics. 2023;15(3):798. doi:10.3390/pharmaceutics15030798
BibTeX
@article{Khabir2023,
author = {Khabir, Zahra and Partalis, Connie and Panchal, Jimit Vijay and Deva, Anand and Khatri, Aparajita and Garcia-Bennett, Alfonso},
title = {Enhanced Skin Penetration of Cannabidiol Using Organosilane Particles as Transdermal Delivery Vehicles},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {3},
pages = {798},
doi = {10.3390/pharmaceutics15030798}
}
EUVIMED